Would you favor oral bisphosphonates over intravenous formulations for patients with hormone sensitive prostate cancer and androgen deprivation therapy (ADT) related osteopenia?

If kidney function is normal, either would do. Therapy depends on the risk level. (See Cosman et al., PMID 39073912.)

If tolerated, oral bisphosphonates are effective and usually first choice. ALSO THE CHEAPEST.